Charles Schwab’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $57.5M | Buy |
1,331,473
+49,244
| +4% | +$2.13M | 0.01% | 1015 |
|
|
2025
Q1 | $44.3M | Sell |
1,282,229
-24,536
| -2% | -$848K | 0.01% | 1155 |
|
|
2024
Q4 | $35.9M | Buy |
1,306,765
+21,963
| +2% | +$603K | 0.01% | 1356 |
|
|
2024
Q3 | $32.7M | Buy |
1,284,802
+95,605
| +8% | +$2.43M | 0.01% | 1399 |
|
|
2024
Q2 | $30.1M | Buy |
1,189,197
+141,160
| +13% | +$3.58M | 0.01% | 1412 |
|
|
2024
Q1 | $32.4M | Sell |
1,048,037
-75,183
| -7% | -$2.32M | 0.01% | 1308 |
|
|
2023
Q4 | $45.3M | Buy |
1,123,220
+66,945
| +6% | +$2.7M | 0.01% | 1048 |
|
|
2023
Q3 | $27.9M | Buy |
1,056,275
+93,324
| +10% | +$2.46M | 0.01% | 1278 |
|
|
2023
Q2 | $16.6M | Buy |
962,951
+38,129
| +4% | +$656K | ﹤0.01% | 1620 |
|
|
2023
Q1 | $15.3M | Buy |
924,822
+128,703
| +16% | +$2.13M | ﹤0.01% | 1653 |
|
|
2022
Q4 | $6.07M | Buy |
796,119
+24,463
| +3% | +$186K | ﹤0.01% | 2121 |
|
|
2022
Q3 | $7.67M | Sell |
771,656
-298,503
| -28% | -$2.97M | ﹤0.01% | 1983 |
|
|
2022
Q2 | $9.72M | Sell |
1,070,159
-8,923
| -0.8% | -$81K | ﹤0.01% | 1844 |
|
|
2022
Q1 | $11M | Buy |
1,079,082
+33,792
| +3% | +$343K | ﹤0.01% | 1903 |
|
|
2021
Q4 | $17.4M | Sell |
1,045,290
-2,202
| -0.2% | -$36.7K | 0.01% | 1691 |
|
|
2021
Q3 | $49.1M | Buy |
1,047,492
+320,410
| +44% | +$15M | 0.02% | 878 |
|
|
2021
Q2 | $44.3M | Buy |
727,082
+37,550
| +5% | +$2.29M | 0.01% | 960 |
|
|
2021
Q1 | $42.5M | Buy |
689,532
+161,089
| +30% | +$9.92M | 0.02% | 951 |
|
|
2020
Q4 | $37.6M | Buy |
528,443
+5,900
| +1% | +$420K | 0.01% | 964 |
|
|
2020
Q3 | $19.6M | Buy |
522,543
+264,132
| +102% | +$9.91M | 0.01% | 1219 |
|
|
2020
Q2 | $8.43M | Buy |
258,411
+3,693
| +1% | +$120K | ﹤0.01% | 1744 |
|
|
2020
Q1 | $7.39M | Buy |
254,718
+121,687
| +91% | +$3.53M | ﹤0.01% | 1628 |
|
|
2019
Q4 | $4.66M | Buy |
133,031
+6,788
| +5% | +$238K | ﹤0.01% | 2050 |
|
|
2019
Q3 | $2.71M | Buy |
+126,243
| New | +$2.71M | ﹤0.01% | 2277 |
|